Regen Report https://validator.w3.org/feed/docs/rss2.html TISSIUM Earns CE Mark for Non-Penetrating Ventral Hernia Mesh Fixation Device Curi Bio Expands Curiverse 3D Tissue Ecosystem with New Disease Models, Casting Kits, and Assay Services Cellbox Solutions Closes EUR 5 Million Series A to Expand Warm-Chain Logistics for Cells and Tissues FibroBiologics Receives Australian Patent Acceptance for Cellular Blend to Regenerate Cartilage in Degenerated Spinal Discs Rznomics’ RNA-Editing Gene Therapy Receives EU Orphan Designation for Glioma Evia Bio Announces Availability of GMP-Grade DMSO-Free Cryopreservation Media for Mesenchymal Stromal Cells ImmuneBridge Partners with Bloodworks Bio to Use Public Cord Blood for Allogeneic Cell Therapy Development Exogenus Therapeutics Leads €13M Consortium to Advance Umbilical Cord Blood Secretome Therapy for Osteoarthritis Laxco Introduces CellLive Series for Continuous Live-Cell Imaging Inside Standard Incubators BioCardia Completes Japan Regulatory Consultations for Its Catheter-Based Cardiac Cell Therapy for Ischemic Heart Failure Porton Advanced Announces FDA Acceptance of Drug Master File for Umbilical Cord Stem Cell-Derived Exosomes Bristol Myers Squibb Reports Interim Phase 1 Results for CD19-Directed CAR T Cell Therapy in Multiple Sclerosis Zymeworks Licenses Trispecific T Cell Engager Targeting DLL3 to Roche AbelZeta Receives FDA RMAT and Fast Track Designations for Anti-CD20/CD19 Bispecific CAR-T Therapy in Relapsed or Refractory Large B-Cell Lymphoma Capricor Therapeutics’ Cardiosphere-Derived Cell Therapy Trial Abstract Wins Cardiology Award Creative Medical Technology Holdings Reports 93% Response Rate in Six-Month Pilot Study of Investigational Ultrasome for Knee Osteoarthritis Cellares and Seoul National University Hospital to Test Automated Manufacturing for a Gene-Modified Blood Stem Cell Therapy Matricelf Receives FDA Feedback Supporting Proposed First-in-Human Trial Design for NewRal in Traumatic Spinal Cord Injury YiPSCELL Receives Korean Patent Registration Decision for Low-Immunogenicity Universal iPSC Technology INmune Bio and Uniphar Team Up to Support International Access to Umbilical Cord-Derived Cell Therapy for RDEB Lonza to Acquire Five US CDMO Manufacturing Sites From Merck KGaA, Darmstadt, Germany Geneva University Hospitals Receives Over CHF 1 Million to Join Phase III Trial of Autologous Bone Marrow Cell Therapy for Advanced Heart Failure SmartCella Licenses Extroducer Endovascular Delivery Platform to HeartWorks for iPSC-Derived Cardiac Cell Therapies Safi Biotherapeutics Receives $4.7 Million Department of War Award Extension to Advance Manufactured Red Blood Cells Toward Planned 2027 IND Submission StimLabs Launches DermaForm Porcine-Derived Particulate Collagen Scaffold for Wound Management ABEC Launches ATB-2100 Advanced Therapy Bioreactor for Cell and Gene Therapy Manufacturing Miltenyi Biotec Joins European Consortium Developing Off-the-Shelf iPSC-Derived NK Cell Therapy for Multiple Myeloma Cabaletta Bio Reports One-Year Rese-cel Responses in Dermatomyositis and Safety Profile Across 71 Autoimmune Disease Patients New Trial – Mesenchymal Stem Cell Exosomes for Non-Dialysis Chronic Kidney Disease New Trial – Collagen Scaffold for Repair of Talus Cartilage Injury Xylyx Bio Announces FDA Orphan Drug Designation and NIH Grant for Investigational Human Whole-Lung Graft Pluri and ZEO ScientifiX Team Up to Expand U.S. Regenerative Medicine Manufacturing and Commercialization Kyverna Therapeutics Reports One-Year Phase 2 Results for CAR T-Cell Therapy in Stiff Person Syndrome Darwin Biotechnology Enrolls First Patient in Phase II Trial of MSC-Derived Protein Complex for Persistent Neurological Deficits After Ischemic Stroke Made Scientific and CARR Biosystems Partner on Single-Use Centrifugation for Cell Therapy Manufacturing BioCardia Advances Helix Catheter Toward FDA Marketing Clearance With De Novo Pre-Submission Acceptance iReprogram Named Lead Industry Partner in University of Michigan’s New Cell Reprogramming Initiative for Diabetes Porton Advanced and Ascist Biotech Partner to Advance IND Submission in China for Adult Pancreatic Progenitor Cell Therapy for Diabetes XellSmart’s iPSC-Derived Dopaminergic Neural Progenitor Cell Therapy Shows Motor Improvements in Phase I Parkinson’s Trial and Completes Phase II Enrollment Webinar: Reimagining Gene-Modified T Cell Manufacturing: New Data on Integrating Isolation, Activation, Transduction, and Expansion in a Single Quantum Flex™ Workflow Webinar: Scaling iPSC Therapies Without Scaling Variability Webinar: Inside eXmoor’s Cell & Gene GMP Facility, Designed for Uncertainty Fate Therapeutics Presents Updated Preliminary Data on iPSC-Derived CAR-T for Active Lupus Nephritis Octane Biotech and Currus Biologics Automate CAR T-Cell Therapy Manufacturing Amish-Backed Gene Therapy Company, Plowshare Therapies, Raises $6.7 Million PBS Biotech Teaming Up With Rockwell Automation to Scale Up Cell Therapy Development Boston Children’s Hospital Launches Consortium to Develop Bioengineered Heart Tissues for Children BrightPath Presents Preclinical Data and Phase 1 Trial Design for iPSC-Derived CAR-iNKT Therapy for Multiple Myeloma Century Therapeutics Reports Sustained Glucose Control With iPSC-Derived Islets in Diabetic Mice, IND Soon Homepage